Palantir Stock Drops for 3rd Day. ARK Invest Unloads More Shares.

Barrons12:46 ET

Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock

Kevin Travers11:06 ET

Shake Shack, Morgan Stanley, Synovus Financial And A Communication Services Stock On CNBC's 'Final Trades'

BenzingaJan 8 08:52 ET

Today's Analyst Rating | UBS Upgrades Bank of America to Buy, Salesforce Price Target Raised to $400 by Needham

Moomoo NewsJan 8 08:00 ET · Ratings

Morgan Stanley: Maintains "Shareholding" rating for Giant Biotechnology with a Target Price of 65 Hong Kong dollars.

Morgan Stanley released a research report stating that it expects the stock price of Gigot Biotech (02367) to rise by about 70% to 80% over the next 15 days, setting its Target Price at HKD 65 and giving it a "Shareholding" rating. The bank forecasts the company's earnings growth for the fiscal years 2024 and 2025 to be 37% and 23%, respectively, indicating that the upcoming annual performance may be stronger than that of other companies within the bank's coverage. The report mentioned that Gigot Biotech's stock price has fallen by about 12% since mid-December last year, and the bank has not yet identified a fundamental reason but believes that the relevant performance is mainly influenced by market allocation. The bank also believes that if measured by 2025.

Sina Hong Kong StockJan 8 04:09 ET

Citigroup expects the Indian stock market to rise by 10% this year, marking the 10th consecutive year of growth.

Citigroup expects that the Indian stock market, which is valued at 5 trillion dollars, will rise for the 10th consecutive year this year, driven by economic growth recovery and strong corporate profits. Citigroup has set a target of 26,000 points for India's benchmark stock index, the Nifty 50 Index, which means the index will rise 10% compared to its closing position at the end of last year. The index is expected to close in 2024 at about 5% higher than the Wall Street bank's forecast of 22,500 points. Strategists at Citigroup, including Surendra Goyal, wrote in a report, "Considering the diversification of listed companies, India"

环球市场播报Jan 8 02:00 ET